| Investor Type | Firm |
| Type of Fund | VC |
| Stages | Seed |
PBM Capital is a venture capital firm based in the United States that specializes in the seed stage investment niche. Their investment thesis revolves around partnering with brilliant minds and daring to advance scientific research into transformative therapies, particularly in fields that can lead to life-changing outcomes.
They focus on providing resources to scientists and entrepreneurs with the objective of bringing innovative products to market and elevating businesses to greater heights. PBM Capital builds long-term value through the application of their extensive industry knowledge, strategic relationship leverage, and delivering operational expertise with a proven track record.
At PBM Capital, the team believes in creating partnerships that spark significant development and growth in their portfolio companies, which are recognized for their impact on the world through their visionary people and life-changing therapies. The firm supported Dr. Brian Kasper, the Chief Scientific Officer of AveXis, by providing crucial funding at a key point in the company’s development, showcasing their commitment to nurturing potential breakthrough endeavors in the science and healthcare sectors.
PBM Capital’s portfolio showcases a range of companies that reflect their mission to effectuate positive impacts through innovation in therapies and visionary leadership. The firm maintains offices in Charlottesville, Virginia, and New York, New York, with a dedicated team poised to work closely with their investments.









